# The National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc.) (EU Exit) Regulations 2019, Regulation 9: The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004

Extent: E+W+S+N.I.

(1) The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 are amended as follows.
(2) In Schedule 2 (drugs, medicines and other substances that may be ordered only in certain circumstances), in the entry in column 2 of the table that corresponds to the entry in column 1 relating to drugs for the treatment of erectile dysfunction—
(a) for sub-paragraph (b) (including the “or” at the end) substitute—
“(b) a man who is a national of an EEA State who—
(i) immediately before IP completion day was entitled to treatment by virtue of Article 7(2) of Council Regulation 1612/68 as extended by the EEA Agreement or was entitled to treatment by virtue of any other enforceable EU right;
(ii) has erectile dysfunction and was on 14th September 1998 receiving a course of treatment under a national health insurance system of an EEA State for that condition with any of the drugs listed in sub-paragraph (a); and
(iii) immediately before IP completion day was receiving a course of treatment as part of the health service for the condition mentioned in paragraph (ii) of this sub-paragraph with any of the drugs listed in sub-paragraph (a); or”;
(b) for sub-paragraph (c) (including the “or” at the end) substitute—
“(c) a man who is not a national of an EEA State but who is the member of the family of such a national and who—
(i) immediately before IP completion day had an enforceable EU right to be treated no less favourably than the national in the provision of medical treatment;
(ii) has erectile dysfunction and was on 14th September 1998 receiving a course of treatment for that condition with any of the drugs listed in sub-paragraph (a); and
(iii) immediately before IP completion day was receiving a course of treatment as part of the health service for the condition mentioned in paragraph (ii) of this sub-paragraph with any of the drugs listed in sub-paragraph (a); or”.

---
Source: https://www.legislation.gov.uk/uksi/2019/777/regulation/9 (the official version)
Page: https://openlegislation.uk/national-health-service-cross-border-healthcare-and-miscellaneous-amendments-etc-eu-exit-regulations-2019/regulation-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

